FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18551711000001106: Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Mar 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63655201000001116 Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63655301000001113 Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Is a Pramipexole 350microgram tablets true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Has active ingredient Pramipexole true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate false Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Has basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) 30 tablet Has AMP True Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) 100 tablet Has AMP True Pramipexole 350microgram tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start